Lista de obras - Roslyn J Francis - Dominio Público Uruguay

(68) Ga-somatostatin analogue PET-CT: Analysis of costs and benefits in a public hospital setting.

artículo científico

3-year freedom from progression following 68GaPSMA PET CT triaged management in men with biochemical recurrence post radical prostatectomy. Results of a prospective multi-center trial

artículo científico publicado en 2019

A Multicenter Prospective Clinical Trial of 68Gallium PSMA HBED-CC PET-CT Restaging in Biochemically Relapsed Prostate Carcinoma: Oligometastatic Rate and Distribution Compared With Standard Imaging

scientific article published on 16 March 2019

A Multimodality Imaging Review of Malignant Pleural Mesothelioma Response Assessment

artículo científico publicado en 2011

A Phase I Clinical Trial of CHT-25 a 131I-Labeled Chimeric Anti-CD25 Antibody Showing Efficacy in Patients with Refractory Lymphoma

artículo científico publicado en 2009

A Phase II Study of Intermittent Sunitinib Malate as Second-Line Therapy in Progressive Malignant Pleural Mesothelioma

artículo científico publicado en 2012

A gelatin liver phantom of suspended 90Y resin microspheres to simulate the physiologic microsphere biodistribution of a postradioembolization liver.

artículo científico publicado en 2014

A multicentre comparison of quantitative (90)Y PET/CT for dosimetric purposes after radioembolization with resin microspheres : The QUEST Phantom Study.

artículo científico publicado en 2015

A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma.

artículo científico publicado en 2015

A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug.

artículo científico publicado en 2006

A pilot study of the utility of choline PET-CT in prostate cancer biochemical relapse following radical prostatectomy.

artículo científico publicado en 2016

A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial pr

artículo científico publicado en 2018

Baseline and Post-treatment 18F-Fluorocholine PET/CT Predicts Outcomes in Hepatocellular Carcinoma Following Locoregional Therapy

scientific article published on 22 August 2019

Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT.

artículo científico publicado en 2015

Comparison between gallium-68 citrate positron emission tomography-computed tomography and gallium-67 citrate scintigraphy for infection imaging

artículo científico publicado en 2019

Coronary <sup>18</sup>F-sodium fluoride PET detects high-risk plaque features on optical coherence tomography and CT-angiography in patients with acute coronary syndrome

artículo científico publicado en 2020

Coronary artery 18F-NaF PET analysis with the use of an elastic motion correction software

artículo científico publicado en 2019

Detection of hypoxia with 18F-fluoromisonidazole (18F-FMISO) PET/CT in suspected or proven pancreatic cancer.

artículo científico publicado en 2013

Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans.

artículo científico publicado en 2007

Imaging in pleural mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group

artículo científico publicado en 2018

Imaging in pleural mesothelioma: a review of imaging research presented at the 9th International Meeting of the International Mesothelioma Interest Group.

scientific article published on 11 June 2010

In search of the vulnerable patient or the vulnerable plaque: F-sodium fluoride positron emission tomography for cardiovascular risk stratification

artículo científico publicado en 2018

Interventional therapies for malignant pleural effusions: the present and the future.

artículo científico publicado en 2014

Is FCH PET able to identify foci of infection superiorly to FDG PET?

artículo científico publicado en 2017

Is Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Cost-effective in Prostate Cancer: An Analysis Informed by the proPSMA Trial

artículo científico publicado en 2020

Mycobacterium mimicking metastatic melanoma

artículo científico

Observer variability in mesothelioma tumor thickness measurements: defining minimally measurable lesions.

artículo científico publicado en 2014

Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres

artículo científico publicado en 2013

Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesoth

artículo científico publicado en 2019

Radiomics for Identification and Prediction in Metastatic Prostate Cancer: A Review of Studies

publication published on 01 November 2021

Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden.

artículo científico publicado en 2010

The impact of (68)Ga-PSMA PET/CT on management intent in prostate cancer: results of an Australian prospective multicenter study.

artículo científico publicado en 2017

TheraP: a randomized phase 2 trial of 177 Lu-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603)

scientific article published on 22 October 2019

Lista de obras de Roslyn J Francis

(68) Ga-somatostatin analogue PET-CT: Analysis of costs and benefits in a public hospital setting.

3-year freedom from progression following 68GaPSMA PET CT triaged management in men with biochemical recurrence post radical prostatectomy. Results of a prospective multi-center trial

A Multicenter Prospective Clinical Trial of 68Gallium PSMA HBED-CC PET-CT Restaging in Biochemically Relapsed Prostate Carcinoma: Oligometastatic Rate and Distribution Compared With Standard Imaging

A Multimodality Imaging Review of Malignant Pleural Mesothelioma Response Assessment

A Phase I Clinical Trial of CHT-25 a 131I-Labeled Chimeric Anti-CD25 Antibody Showing Efficacy in Patients with Refractory Lymphoma

A Phase II Study of Intermittent Sunitinib Malate as Second-Line Therapy in Progressive Malignant Pleural Mesothelioma

A gelatin liver phantom of suspended 90Y resin microspheres to simulate the physiologic microsphere biodistribution of a postradioembolization liver.

A multicentre comparison of quantitative (90)Y PET/CT for dosimetric purposes after radioembolization with resin microspheres : The QUEST Phantom Study.

A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma.

A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug.

A pilot study of the utility of choline PET-CT in prostate cancer biochemical relapse following radical prostatectomy.

A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial pr

Baseline and Post-treatment 18F-Fluorocholine PET/CT Predicts Outcomes in Hepatocellular Carcinoma Following Locoregional Therapy

Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT.

Comparison between gallium-68 citrate positron emission tomography-computed tomography and gallium-67 citrate scintigraphy for infection imaging

Coronary <sup>18</sup>F-sodium fluoride PET detects high-risk plaque features on optical coherence tomography and CT-angiography in patients with acute coronary syndrome

Coronary artery 18F-NaF PET analysis with the use of an elastic motion correction software

Detection of hypoxia with 18F-fluoromisonidazole (18F-FMISO) PET/CT in suspected or proven pancreatic cancer.

Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans.

Imaging in pleural mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group

Imaging in pleural mesothelioma: a review of imaging research presented at the 9th International Meeting of the International Mesothelioma Interest Group.

In search of the vulnerable patient or the vulnerable plaque: F-sodium fluoride positron emission tomography for cardiovascular risk stratification

Interventional therapies for malignant pleural effusions: the present and the future.

Is FCH PET able to identify foci of infection superiorly to FDG PET?

Is Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Cost-effective in Prostate Cancer: An Analysis Informed by the proPSMA Trial

Mycobacterium mimicking metastatic melanoma

Observer variability in mesothelioma tumor thickness measurements: defining minimally measurable lesions.

Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres

Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesoth

Radiomics for Identification and Prediction in Metastatic Prostate Cancer: A Review of Studies

Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden.

The impact of (68)Ga-PSMA PET/CT on management intent in prostate cancer: results of an Australian prospective multicenter study.

TheraP: a randomized phase 2 trial of 177 Lu-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603)